nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0447	0.291	CbGbCtD
Bisoprolol—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0416	0.271	CbGbCtD
Bisoprolol—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0191	0.124	CbGbCtD
Bisoprolol—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0188	0.122	CbGbCtD
Bisoprolol—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0175	0.114	CbGbCtD
Bisoprolol—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0119	0.0777	CbGbCtD
Bisoprolol—Chlorphenesin—BCHE—peripheral nervous system neoplasm	0.00466	0.452	CrCbGaD
Bisoprolol—Atenolol—ABCB1—peripheral nervous system neoplasm	0.00183	0.177	CrCbGaD
Bisoprolol—Acebutolol—ABCB1—peripheral nervous system neoplasm	0.00169	0.163	CrCbGaD
Bisoprolol—Metoprolol—ABCB1—peripheral nervous system neoplasm	0.00142	0.138	CrCbGaD
Bisoprolol—Propranolol—ABCB1—peripheral nervous system neoplasm	0.000718	0.0696	CrCbGaD
Bisoprolol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000449	0.000537	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000448	0.000535	CcSEcCtD
Bisoprolol—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000535	CcSEcCtD
Bisoprolol—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000447	0.000535	CcSEcCtD
Bisoprolol—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000446	0.000534	CcSEcCtD
Bisoprolol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000445	0.000533	CcSEcCtD
Bisoprolol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000445	0.000533	CcSEcCtD
Bisoprolol—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000532	CcSEcCtD
Bisoprolol—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.00053	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000441	0.000527	CcSEcCtD
Bisoprolol—Infection—Etoposide—peripheral nervous system neoplasm	0.000441	0.000527	CcSEcCtD
Bisoprolol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00044	0.000526	CcSEcCtD
Bisoprolol—Nausea—Melphalan—peripheral nervous system neoplasm	0.00044	0.000526	CcSEcCtD
Bisoprolol—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000437	0.000523	CcSEcCtD
Bisoprolol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000435	0.00052	CcSEcCtD
Bisoprolol—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000434	0.000519	CcSEcCtD
Bisoprolol—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000433	0.000518	CcSEcCtD
Bisoprolol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000433	0.000518	CcSEcCtD
Bisoprolol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000433	0.000518	CcSEcCtD
Bisoprolol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000432	0.000516	CcSEcCtD
Bisoprolol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000431	0.000515	CcSEcCtD
Bisoprolol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000429	0.000513	CcSEcCtD
Bisoprolol—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000511	CcSEcCtD
Bisoprolol—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000511	CcSEcCtD
Bisoprolol—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000423	0.000506	CcSEcCtD
Bisoprolol—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000504	CcSEcCtD
Bisoprolol—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00042	0.000503	CcSEcCtD
Bisoprolol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000419	0.000501	CcSEcCtD
Bisoprolol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000419	0.000501	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000418	0.0005	CcSEcCtD
Bisoprolol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000414	0.000496	CcSEcCtD
Bisoprolol—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000495	CcSEcCtD
Bisoprolol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000414	0.000495	CcSEcCtD
Bisoprolol—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000494	CcSEcCtD
Bisoprolol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000408	0.000488	CcSEcCtD
Bisoprolol—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000484	CcSEcCtD
Bisoprolol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000403	0.000482	CcSEcCtD
Bisoprolol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000402	0.000481	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000477	CcSEcCtD
Bisoprolol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000399	0.000477	CcSEcCtD
Bisoprolol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000398	0.000476	CcSEcCtD
Bisoprolol—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000398	0.000476	CcSEcCtD
Bisoprolol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000395	0.000473	CcSEcCtD
Bisoprolol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000394	0.000472	CcSEcCtD
Bisoprolol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000393	0.00047	CcSEcCtD
Bisoprolol—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000469	CcSEcCtD
Bisoprolol—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000466	CcSEcCtD
Bisoprolol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00039	0.000466	CcSEcCtD
Bisoprolol—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000465	CcSEcCtD
Bisoprolol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000389	0.000465	CcSEcCtD
Bisoprolol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000386	0.000462	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000383	0.000458	CcSEcCtD
Bisoprolol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000383	0.000458	CcSEcCtD
Bisoprolol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000382	0.000457	CcSEcCtD
Bisoprolol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000379	0.000454	CcSEcCtD
Bisoprolol—Pain—Etoposide—peripheral nervous system neoplasm	0.000379	0.000454	CcSEcCtD
Bisoprolol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000453	CcSEcCtD
Bisoprolol—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000453	CcSEcCtD
Bisoprolol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000376	0.000449	CcSEcCtD
Bisoprolol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000375	0.000448	CcSEcCtD
Bisoprolol—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000447	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000442	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000369	0.000441	CcSEcCtD
Bisoprolol—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.00044	CcSEcCtD
Bisoprolol—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000437	CcSEcCtD
Bisoprolol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000365	0.000437	CcSEcCtD
Bisoprolol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000364	0.000435	CcSEcCtD
Bisoprolol—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000435	CcSEcCtD
Bisoprolol—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000434	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000363	0.000434	CcSEcCtD
Bisoprolol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000362	0.000433	CcSEcCtD
Bisoprolol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000361	0.000432	CcSEcCtD
Bisoprolol—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000431	CcSEcCtD
Bisoprolol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000358	0.000428	CcSEcCtD
Bisoprolol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000358	0.000428	CcSEcCtD
Bisoprolol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000357	0.000427	CcSEcCtD
Bisoprolol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000426	CcSEcCtD
Bisoprolol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000356	0.000426	CcSEcCtD
Bisoprolol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000352	0.000421	CcSEcCtD
Bisoprolol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000351	0.00042	CcSEcCtD
Bisoprolol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000351	0.000419	CcSEcCtD
Bisoprolol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000351	0.000419	CcSEcCtD
Bisoprolol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000419	CcSEcCtD
Bisoprolol—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000419	CcSEcCtD
Bisoprolol—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00035	0.000418	CcSEcCtD
Bisoprolol—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000416	CcSEcCtD
Bisoprolol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000348	0.000416	CcSEcCtD
Bisoprolol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000347	0.000415	CcSEcCtD
Bisoprolol—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000415	CcSEcCtD
Bisoprolol—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000414	CcSEcCtD
Bisoprolol—Rash—Vincristine—peripheral nervous system neoplasm	0.000345	0.000413	CcSEcCtD
Bisoprolol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000345	0.000412	CcSEcCtD
Bisoprolol—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000412	CcSEcCtD
Bisoprolol—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000411	CcSEcCtD
Bisoprolol—Headache—Vincristine—peripheral nervous system neoplasm	0.000343	0.00041	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000408	CcSEcCtD
Bisoprolol—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000405	CcSEcCtD
Bisoprolol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.000404	CcSEcCtD
Bisoprolol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000403	CcSEcCtD
Bisoprolol—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000403	CcSEcCtD
Bisoprolol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000331	0.000396	CcSEcCtD
Bisoprolol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000394	CcSEcCtD
Bisoprolol—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000391	CcSEcCtD
Bisoprolol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000327	0.000391	CcSEcCtD
Bisoprolol—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000326	0.00039	CcSEcCtD
Bisoprolol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000325	0.000389	CcSEcCtD
Bisoprolol—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000388	CcSEcCtD
Bisoprolol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000388	CcSEcCtD
Bisoprolol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000388	CcSEcCtD
Bisoprolol—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000387	CcSEcCtD
Bisoprolol—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000385	CcSEcCtD
Bisoprolol—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000384	CcSEcCtD
Bisoprolol—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000381	CcSEcCtD
Bisoprolol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000318	0.000381	CcSEcCtD
Bisoprolol—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000381	CcSEcCtD
Bisoprolol—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000317	0.00038	CcSEcCtD
Bisoprolol—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000377	CcSEcCtD
Bisoprolol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000314	0.000375	CcSEcCtD
Bisoprolol—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000374	CcSEcCtD
Bisoprolol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000373	CcSEcCtD
Bisoprolol—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000309	0.00037	CcSEcCtD
Bisoprolol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000308	0.000368	CcSEcCtD
Bisoprolol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000367	CcSEcCtD
Bisoprolol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000305	0.000365	CcSEcCtD
Bisoprolol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000305	0.000365	CcSEcCtD
Bisoprolol—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000364	CcSEcCtD
Bisoprolol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000303	0.000363	CcSEcCtD
Bisoprolol—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000362	CcSEcCtD
Bisoprolol—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000361	CcSEcCtD
Bisoprolol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000359	CcSEcCtD
Bisoprolol—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000359	CcSEcCtD
Bisoprolol—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000357	CcSEcCtD
Bisoprolol—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000352	CcSEcCtD
Bisoprolol—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000351	CcSEcCtD
Bisoprolol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000293	0.000351	CcSEcCtD
Bisoprolol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000293	0.00035	CcSEcCtD
Bisoprolol—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000349	CcSEcCtD
Bisoprolol—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000346	CcSEcCtD
Bisoprolol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000288	0.000344	CcSEcCtD
Bisoprolol—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000342	CcSEcCtD
Bisoprolol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000339	CcSEcCtD
Bisoprolol—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000338	CcSEcCtD
Bisoprolol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000282	0.000337	CcSEcCtD
Bisoprolol—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000337	CcSEcCtD
Bisoprolol—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000335	CcSEcCtD
Bisoprolol—Rash—Etoposide—peripheral nervous system neoplasm	0.00028	0.000334	CcSEcCtD
Bisoprolol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000279	0.000334	CcSEcCtD
Bisoprolol—Headache—Etoposide—peripheral nervous system neoplasm	0.000278	0.000332	CcSEcCtD
Bisoprolol—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.00033	CcSEcCtD
Bisoprolol—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000329	CcSEcCtD
Bisoprolol—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000327	CcSEcCtD
Bisoprolol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000327	CcSEcCtD
Bisoprolol—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000326	CcSEcCtD
Bisoprolol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000324	CcSEcCtD
Bisoprolol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000322	CcSEcCtD
Bisoprolol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000268	0.00032	CcSEcCtD
Bisoprolol—Cough—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000318	CcSEcCtD
Bisoprolol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000263	0.000315	CcSEcCtD
Bisoprolol—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000313	CcSEcCtD
Bisoprolol—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000259	0.00031	CcSEcCtD
Bisoprolol—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000259	0.00031	CcSEcCtD
Bisoprolol—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000259	0.00031	CcSEcCtD
Bisoprolol—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.00031	CcSEcCtD
Bisoprolol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000309	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000308	CcSEcCtD
Bisoprolol—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000306	CcSEcCtD
Bisoprolol—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000304	CcSEcCtD
Bisoprolol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000303	CcSEcCtD
Bisoprolol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000303	CcSEcCtD
Bisoprolol—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000302	CcSEcCtD
Bisoprolol—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000251	0.0003	CcSEcCtD
Bisoprolol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000298	CcSEcCtD
Bisoprolol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000297	CcSEcCtD
Bisoprolol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000296	CcSEcCtD
Bisoprolol—Infection—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000295	CcSEcCtD
Bisoprolol—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000294	CcSEcCtD
Bisoprolol—Shock—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000293	CcSEcCtD
Bisoprolol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000292	CcSEcCtD
Bisoprolol—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000291	CcSEcCtD
Bisoprolol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000243	0.00029	CcSEcCtD
Bisoprolol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000289	CcSEcCtD
Bisoprolol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000287	CcSEcCtD
Bisoprolol—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000287	CcSEcCtD
Bisoprolol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000287	CcSEcCtD
Bisoprolol—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000287	CcSEcCtD
Bisoprolol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000286	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000285	CcSEcCtD
Bisoprolol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000284	CcSEcCtD
Bisoprolol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000281	CcSEcCtD
Bisoprolol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000278	CcSEcCtD
Bisoprolol—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000277	CcSEcCtD
Bisoprolol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000275	CcSEcCtD
Bisoprolol—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000273	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000271	CcSEcCtD
Bisoprolol—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000271	CcSEcCtD
Bisoprolol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.00027	CcSEcCtD
Bisoprolol—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000269	CcSEcCtD
Bisoprolol—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000269	CcSEcCtD
Bisoprolol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000268	CcSEcCtD
Bisoprolol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000267	CcSEcCtD
Bisoprolol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000267	CcSEcCtD
Bisoprolol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000266	CcSEcCtD
Bisoprolol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000265	CcSEcCtD
Bisoprolol—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000264	CcSEcCtD
Bisoprolol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000262	CcSEcCtD
Bisoprolol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000257	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000257	CcSEcCtD
Bisoprolol—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000256	CcSEcCtD
Bisoprolol—Pain—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000254	CcSEcCtD
Bisoprolol—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000254	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000251	CcSEcCtD
Bisoprolol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000249	CcSEcCtD
Bisoprolol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000247	CcSEcCtD
Bisoprolol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000245	CcSEcCtD
Bisoprolol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000245	CcSEcCtD
Bisoprolol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000245	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000243	CcSEcCtD
Bisoprolol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000242	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000238	CcSEcCtD
Bisoprolol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000237	CcSEcCtD
Bisoprolol—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000236	CcSEcCtD
Bisoprolol—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000235	CcSEcCtD
Bisoprolol—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000235	CcSEcCtD
Bisoprolol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000235	CcSEcCtD
Bisoprolol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000235	CcSEcCtD
Bisoprolol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000227	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000225	CcSEcCtD
Bisoprolol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000219	CcSEcCtD
Bisoprolol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000219	CcSEcCtD
Bisoprolol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000217	CcSEcCtD
Bisoprolol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000217	CcSEcCtD
Bisoprolol—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000213	CcSEcCtD
Bisoprolol—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00021	CcSEcCtD
Bisoprolol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000203	CcSEcCtD
Bisoprolol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000203	CcSEcCtD
Bisoprolol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000197	CcSEcCtD
Bisoprolol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000197	CcSEcCtD
Bisoprolol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000195	CcSEcCtD
Bisoprolol—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000189	CcSEcCtD
Bisoprolol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000188	CcSEcCtD
Bisoprolol—Rash—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000187	CcSEcCtD
Bisoprolol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000187	CcSEcCtD
Bisoprolol—Headache—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000186	CcSEcCtD
Bisoprolol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000182	CcSEcCtD
Bisoprolol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000177	CcSEcCtD
Bisoprolol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000175	CcSEcCtD
Bisoprolol—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000173	CcSEcCtD
Bisoprolol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000173	CcSEcCtD
Bisoprolol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000172	CcSEcCtD
Bisoprolol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000163	CcSEcCtD
